Singapore markets close in 5 hours 53 minutes
Straits Times Index
3,384.11 -1.82 (-0.05%) Nikkei
27,754.36 +60.71 (+0.22%) Hang Seng
21,489.04 +266.88 (+1.26%) FTSE 100
7,836.71 -65.09 (-0.82%) BTC-USD
22,882.42 -2.73 (-0.01%) CMC Crypto 200
525.13 -0.01 (-0.00%)
Bristol-Myers Squibb Company (BMY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 74.45 |
| Open | 74.45 |
| Bid | 74.57 x 1000 |
| Ask | 75.00 x 800 |
| Day's range | 74.23 - 75.18 |
| 52-week range | 65.60 - 81.44 |
| Volume | |
| Avg. volume | 9,017,385 |
| Market cap | 158.463B |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | 25.26 |
| EPS (TTM) | 2.95 |
| Earnings date | 27 Apr 2023 |
| Forward dividend & yield | 2.28 (3.06%) |
| Ex-dividend date | 05 Jan 2023 |
| 1y target est | 82.49 |
- Motley Fool
Could This Indication Provide a Lift for Bristol Myers Squibb's Stock?
Bristol Myers' Sotyktu recently moved one step closer to its first approval in the European Union.
- Motley Fool
Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?
Shares in pharmaceutical company Bristol Myers Squibb (NYSE: BMY) are up a little more than 11% over the past year. The company posted third-quarter revenue of $11.2 billion, a decrease of 3%, with one culprit being the loss of exclusivity for one of its blockbuster drugs, Revlimid. The blood cancer therapy reported sales of $2.4 billion, down 28% year over year.
© 2023 Yahoo. All rights reserved.
